Case Report: A Case of Locally Advanced Pancreatic Cancer Which Achieved Progression Free for Over 12 Months by Subsequent Therapy with Anlotinib Hydrochloride Plus Tegafur-Gimeracil-Oteracil Potassium (TS-1)

Titled the “most destructive of all cancers”, pancreatic cancer is a malignant tumor with a very poor prognosis and has a poor response to systemic therapy. At present, several studies have shown that tegafur-gimeracil-oteracil potassium (hereinafter referred to as TS-1) is no less superior to gemci...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Dongcheng, Liao, Sina, Li, Qian, Lin, Youzhi, Wei, Junbao, Li, Yongqiang, Liao, Xiaoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283868/
https://www.ncbi.nlm.nih.gov/pubmed/35847852
http://dx.doi.org/10.3389/fonc.2022.862600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283868/
https://www.ncbi.nlm.nih.gov/pubmed/35847852
http://dx.doi.org/10.3389/fonc.2022.862600

Ejemplares similares